Alzheimer's disease & dementia

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.

Diseases, Conditions, Syndromes

Infusion helps repair COVID-19 damage in severe cases

University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken ...

Immunology

Nature's own nanoparticles harnessed to target disease

Using a novel form of immune-genetic therapy, researchers from Yale School of Medicine and the Jagiellonian University College of Medicine in Poland have successfully inhibited a strong immune allergic inflammatory response ...

Diseases, Conditions, Syndromes

Tuberculosis vaccine passes safety test

No other infectious disease has killed more people than tuberculosis. Currently, only one vaccine is available to prevent severe courses: Bacillus Calmette Guérin (BCG). However, it is not equally effective against all types ...

page 12 from 40